Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia. // ASPET Discovery. – URL: https://www.sciencedirect.com/science/article/pii/S3050567425000136?dgcid=rss_sd_all
Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia. ASPET Discovery. https://www.sciencedirect.com/science/article/pii/S3050567425000136?dgcid=rss_sd_all
“Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia.” ASPET Discovery.
@article{article29688,
title = {Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant FLT3- internal tandem duplication acute myeloid leukemia},
journal = {ASPET Discovery},
url = {https://www.sciencedirect.com/science/article/pii/S3050567425000136?dgcid=rss_sd_all}
}